Rachel Nahrwold in New York, New York

Home New York New York

Rachel Nahrwold has Nurse Practitioner as her primary medical specialty. Their primary office is: 130 E 77th St in New York, New York.

They're a part of the: North Shore - Lij Medical Pc medical group which has around 5,005 members. You can call their office at 212-434-2810 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2018 (around 6 years of experience). They are listed as doing telehealth appointments.

Rachel Nahrwold Office Phone and Directions

Rachel Nahrwold
North Shore - Lij Medical Pc
130 E 77th St
New York, New York 10075
212-434-2810

Patient Ratings
Please rate your experience with Rachel Nahrwold below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-434-2810

Enter a starting address:

Healthcare Info for Rachel Nahrwold

Medical School: Sorry, her university is not listed
Graduation Year: 2018
The Primary Medical Specialty for Rachel Nahrwold is listed as: Nurse Practitioner
Approximate Years of Experience: 6
PAC (PECOS ID)#: 1254672157
NPI #: 1417496696
NPI Created On: 02/21/2017
NPI Last Updated Listed as: 01/17/2019
Primary Taxonomy Code: 163W00000X
License Number:
717948
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

New patient office or other outpatient visit, typically 20 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $110

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 763793768

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DIABETES

Name of Drug #1: JARDIANCE

Open Associated Drug #1: 0597-0152-30